Cytospire Therapeutics Limited
14688240
Some Concerns
- 1 outstanding charge (-2)
Details
Compliance
Last accounts
31/03/2025
small
Next accounts due
31/12/2026
Confirmation statement
Last: 23/02/2026
Due 09/03/2027
Industry
Officers
director · Since 24/02/2023
DIRECTOR AND SCIENTIST
BRITISH · UNITED KINGDOM · Age 53
director · Since 02/05/2023
CHIEF INVESTMENT OFFICER
BRITISH · ENGLAND · Age 46
Also on 5 other boards
director · Since 22/11/2023
PARTNER
BRITISH · UNITED KINGDOM · Age 39
Also on 2 other boards
director · Since 25/03/2026
BRITISH · UNITED KINGDOM · Age 40
Also on 7 other boards
Persons with Significant Control
Abingworth Bioventures 8 Gp Lp
50, Lothian Road, Edinburgh, EH3 9WJ
Reg: Sl034057 · Companies House · Corporate
Notified 28/04/2023
Former PSCs
Natalie Marianne Mount
Ceased 30/11/2023
Mark Uden
Ceased 30/11/2023
4bio Ventures Iii Gp Llp
Ceased 03/10/2024
Charges1 outstanding
HSBC INNOVATION BANKING
HSBC INNOVATION BANKING PREVIOUSLY KNOWN AS SILICON VALLEY BANK UK LIMITED